The Association Between METS-IR and Serum Ferritin Level in United States Female: A Cross-Sectional Study Based on NHANES.

National Health and Nutrition Examination Survey (NHANES) cross-sectional studies insulin resistance metabolic score for insulin resistance serum ferritin

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2022
Historique:
received: 21 04 2022
accepted: 07 06 2022
entrez: 15 7 2022
pubmed: 16 7 2022
medline: 16 7 2022
Statut: epublish

Résumé

The aim of this study was to investigate the association between the metabolic score for insulin resistance (METS-IR) and serum ferritin in females from the United States. We conducted a cross-sectional study with 4,182 participants from the National Health and Nutrition Examination Survey (NHANES). We used METS-IR and serum ferritin as the independent and dependent variables in this study and investigated the relationship by using multiple linear regression and verified the non-linear relationship with a smooth curve fit and threshold effect model. There was a positive relationship between METS-IR and serum ferritin, with an effect value of (β = 0.29, 95% CI: 0.14-0.44) in a fully adjusted model adjusted for potential confounders. This positive correlation became more significant as METS-IR increased (p for trend < 0.001). Subsequent subgroup analyses showed that sensitive cohorts were those aged ≥40 years, black, and with a body mass index (BMI) < 24.9 kg/m There was a positive association between METS-IR and serum ferritin in United States females, and this positive association was more pronounced in participants aged ≥40 years, black race and BMI < 24.9 kg/m

Identifiants

pubmed: 35836938
doi: 10.3389/fmed.2022.925344
pmc: PMC9273928
doi:

Types de publication

Journal Article

Langues

eng

Pagination

925344

Informations de copyright

Copyright © 2022 Hao, Chen, Xiaojuan, Siqi, Hailiang, Xiaoxing, Qikai, Mingquan, Jiangzhou and Hongfeng.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Liver Cancer. 2017 Nov;6(4):307-312
pubmed: 29234634
Cardiovasc Diabetol. 2022 Feb 16;21(1):26
pubmed: 35172838
Front Med (Lausanne). 2022 Mar 21;9:865669
pubmed: 35386917
Diabetes Metab Res Rev. 2013 May;29(4):308-18
pubmed: 23381919
Nagoya J Med Sci. 2012 Feb;74(1-2):39-49
pubmed: 22515110
Mol Metab. 2021 Sep;51:101235
pubmed: 33872860
Am J Gastroenterol. 2022 Feb 1;117(2):311-318
pubmed: 34904966
Br J Haematol. 2018 May;181(3):331-340
pubmed: 29672840
J Clin Lab Anal. 2022 Feb;36(2):e24225
pubmed: 34997649
Obes Res. 2005 Aug;13(8):1458-65
pubmed: 16129729
Eur J Endocrinol. 2018 May;178(5):533-544
pubmed: 29535168
Lipids Health Dis. 2017 Dec 2;16(1):228
pubmed: 29197393
Ann Med. 2022 Dec;54(1):622-632
pubmed: 35175162
PLoS One. 2017 Dec 22;12(12):e0190310
pubmed: 29272309
Diab Vasc Dis Res. 2015 May;12(3):189-98
pubmed: 25670848
Diabetes Care. 2013 Apr;36(4):845-53
pubmed: 23223406
Diabetes Care. 2002 Mar;25(3):494-9
pubmed: 11874936
Diabetes. 2001 Feb;50(2):315-21
pubmed: 11272142
J Am Heart Assoc. 2017 Jan 23;6(1):
pubmed: 28115312
Transl Gastroenterol Hepatol. 2020 Apr 05;5:25
pubmed: 32258529
Children (Basel). 2022 Feb 21;9(2):
pubmed: 35205011
Diabetes Care. 2021 Nov;44(11):2586-2588
pubmed: 34521638
Mol Cell Endocrinol. 2015 Feb 15;402:113-9
pubmed: 25578600
J Endocrinol Invest. 2009 Sep;32(8):704-16
pubmed: 19494706
Nutrients. 2022 Feb 22;14(5):
pubmed: 35267895
Curr Med Res Opin. 2005 Aug;21(8):1157-9
pubmed: 16083523
J Trace Elem Med Biol. 2021 Dec;68:126824
pubmed: 34352498
BMJ Open. 2022 Mar 21;12(3):e058517
pubmed: 35314476
Cardiovasc Diabetol. 2018 Aug 31;17(1):122
pubmed: 30170598
Front Physiol. 2022 Feb 02;13:809669
pubmed: 35185617
Hematology Am Soc Hematol Educ Program. 2001;:47-61
pubmed: 11722978
Diabetes Metab J. 2022 Mar;46(2):307-318
pubmed: 35249273
J Hepatol. 2016 Feb;64(2):505-515
pubmed: 26596411
Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S9-18
pubmed: 17699375

Auteurs

Han Hao (H)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Yan Chen (Y)

Department of General Practice, Wuhu City Second People's Hospital, Wuhu, China.

Ji Xiaojuan (J)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Zhang Siqi (Z)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Chu Hailiang (C)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Sun Xiaoxing (S)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Wang Qikai (W)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Xing Mingquan (X)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Feng Jiangzhou (F)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Ge Hongfeng (G)

Department of Hematology, Anhui Medical University Affiliated to Bozhou People's Hospital, Bozhou, China.

Classifications MeSH